TSE Filings
2023
-
Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2024 (Under IFRS)
-
Corporate Split in Tandem with Intergroup Organizational Restructuring
-
Notice Regarding Distribution of Dividends from Surplus
-
Announcement Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2024
-
(Updated) Notice Regarding Partial Amendments of “Notice Regarding Distribution of Dividends from Surplus”
-
Consolidated Financial Results for the Fiscal Year Ended March 31, 2023 (Under IFRS)
-
Notice Concerning Change of Major Shareholder
-
Notice regarding Specific Action Plan and Update of Performance Targets related to Management Policy "Forging the future"
-
Notice on Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2023
-
Notice of Award for the Arbitration Filed against Mitsubishi Tanabe Pharma Corporation, a Consolidated Subsidiary
-
Earnings Impact due to Cessation of MMA-related Product Production at Mitsubishi Chemical UK Limited and Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2023
-
Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2023
-
Notice on Absorption-type Merger of a Wholly-owned Subsidiary (Simplified Merger and Short-form Merger)
-
Notice Regarding Changes in Representative Corporate Executive Officer
2022
-
Notice on Cessation of the Production of Methacrylates in Mitsubishi Chemical UK Limited
-
Notice on the Start of Consultation on Cessation of the Production of Methacrylates in Mitsubishi Chemical UK Limited
-
Notice On Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2023
-
Consolidated Financial Results for the First Half of the Fiscal Year Ending March 31, 2023 (Under IFRS)
-
Corporate Split in Tandem with Intergroup Organizational Restructuring
-
Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2023 (Under IFRS)
-
Regarding Some News Reports Today
-
Notice on Change of Trade Name and Partial Amendment to Articles of Incorporation
-
Announcement Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2024
-
Notice Regarding Distribution of Dividends from Surplus
-
Consolidated Financial Results for the Fiscal Year Ended March 31, 2022 (Under IFRS)
-
Notice Regarding Disposition of Treasury Shares as Equity Compensation in the Form of Restricted Shares
-
Notice on Absorption-type Merger of a Wholly-owned Subsidiary (Simplified Merger and Short-form Merger)
-
Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2022 (Under IFRS)
-
Notice Regarding Changes in Representative Corporate Executive Officers
2021
-
Formulation of New Management Policy “Forging the future”
-
Notice of Changes Regarding the Corporate Executive Officer and Chief Financial Officer
-
Notice of Revision to Consolidated Financial Results Forecast, Distribution of Dividend (Interim Dividend) of Surplus, and Revision to Year-end Dividend Forecast for the Fiscal Year Ending March 31, 2022
-
Consolidated Financial Results for the First Half of the Fiscal Year Ending March 31, 2022 (Under IFRS)
-
Notice on Company Split (Simplified Absorption-type Company Split) and Share Transfer in Line with Transfer of the Polycrystalline Alumina Fiber Business of the Consolidated Subsidiary (Mitsubishi Chemical Corporation)
-
Notice Regarding Revision to Consolidated Financial Results Forecast for the First Half of Fiscal Year Ending March 31, 2022
-
Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2022 (Under IFRS)
-
Notice on Continuation of Performance-based Share Compensation Program Which Uses a Trust
-
Announcement Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2022 and Zero Coupon Convertible Bonds due 2024
-
Notice Regarding Distribution of Dividends from Surplus
-
Consolidated Financial Results for the Fiscal Year Ended March 31, 2021 (Under IFRS)
-
Notice Regarding Differences between Financial Results Forecast and Financial Results for the Fiscal Year Ended March 31, 2021
-
Notice Regarding Disposition of Treasury Shares as Equity Compensation in the Form of Restricted Shares and Introduction of Performance-Linked Equity Compensation (Performance Share Unit) Scheme
-
Formulation of New Medium-Term Management Plan APTSIS 25 Step 1
-
Notice Regarding Changes in Representative Corporate Executive Officers
-
Condensed Consolidated Financial Information for the Third Quarter of the Fiscal Year Ending March 31, 2021
-
Notice Regarding Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2021
2020
-
Condensed Consolidated Financial Information for the First Half of the Fiscal Year Ending March 31, 2021
-
Notice Regarding Differences between Financial Results Forecast and
Financial Results for the First Half of Fiscal 2020, and Revisions to Annual Forecast -
Mitsubishi Chemical to End MMA Monomer and MAA Production in Texas and Close Site
-
Notice Regarding the Recording of Impairment Loss
-
Notice Regarding Change in Representative Corporate Executive Officers
-
Condensed Consolidated Financial Information for the First Quarter of the Fiscal Year Ending March 31, 2021
-
Notice Regarding Disposition of Treasury Shares as Equity Compensation in the
Form of Restricted Shares -
Notice Regarding Distribution of Dividends from Surplus
-
Announcement Regarding Adjustment of Conversion Price for
Zero Coupon Convertible Bonds due 2022 and
Zero Coupon Convertible Bonds due 2024 -
Taiyo Nippon Sanso Corporation Announces
Notice of Absorption-Type Company Split Agreement for Transition to a Holding Company Structure Through Company Split and Partial Amendments to Articles of Incorporation (Tradename and Business Purpose) -
Condensed Consolidated Financial Information for the Fiscal Year Ended March 31, 2020
-
Notice of Revision to Consolidated Financial Results Forecast and Dividends Forecast for the Fiscal Year Ended March 31, 2020
-
Notice on Revision to Consolidated Financial Results Forecast
for the Fiscal Year Ending March 31, 2020 -
Consolidated Financial Information for the Third Quarter of the Fiscal Year Ending March 31, 2020
-
Taiyo Nippon Sanso Corporation Announces “Notice of Transition to a Holding Company Structure Through Company Split, Incorporation of a Subsidiary (Company-Split Preparation Company), and Partial Amendment to the Articles of Incorporation (Tradename Change)”
-
Announcement in Relation to Results of Tender Offer for Shares of Mitsubishi Tanabe Pharma Corporation (Securities Code: 4508)
2019
-
Announcement of Commencement of Tender Offer for Shares of Mitsubishi Tanabe Pharma Corporation (Securities Code: 4508)
-
Consolidated Financial Information for the First Half of the Fiscal Year Ending March 31, 2020
-
Notice on Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2020
-
Consolidated Financial Information for the First Quarter of the Fiscal Year Ending March 31, 2020
-
Notice Regarding Distribution of Dividends from Surplus
-
Announcement Regarding Adjustment of Conversion Price for
Zero Coupon Convertible Bonds due 2022 and
Zero Coupon Convertible Bonds due 2024 -
Condensed Consolidated Financial Information for the Fiscal Year Ended March 31, 2019
-
Taiyo Nippon Sanso Corporation Announces
“Notice Regarding Financing through a Subordinated Loan” -
Notice Regarding Completed Acquisition of a HyCO Business and Related Assets
in the United States -
Notice Regarding Changes in Representative Corporate Executive Officers
-
Mitsubishi Tanabe Pharma Corporation Received Notice of Request for Arbitration
-
Consolidated Financial Information for the Third Quarter of the Fiscal Year Ending March 31, 2019
-
Taiyo Nippon Sanso Corporation Announces
“Notice Regarding Determination of Issuance Conditions for Hybrid Bonds
(Public Subordinated Bonds)”
2018
-
Taiyo Nippon Sanso Corporation Announces “Notice Regarding Acquisition of
a HyCO Business and Related Assets in the United States” -
Revision of Targets under Medium-Term Management Plan APTSIS20
-
Taiyo Nippon Sanso Corporation Announces “Notice Regarding Issue of Hybrid Bonds (Public Subordinated Bonds)”
-
Taiyo Nippon Sanso Corporation Announces“Notice Regarding Completed Acquisition (100% Ownership) Procedures of US Company Praxair, Inc.’s European Businesses”
-
Taiyo Nippon Sanso Corporation Announces Notice of Conclusion of Bridge Loan Agreement Concerning Acquisition (100% Ownership) of US Company, Praxair, Inc.’s European Businesses
-
Notice Regarding Changes in Specified Subsidiaries
-
Revision of Forecasts for Consolidated Financial Results and Dividends for Fiscal Year Ending March 31, 2019
-
Consolidated Financial Information for the First Half of the Fiscal Year Ending March 31, 2019
-
Notice Regarding Differences between Consolidated Financial Results Forecast and Financial Results for the First Half of the Fiscal Year Ending March 31, 2019
-
Notice Regarding Distribution of Dividends from Surplus (Interim Dividend)
-
Notice Regarding Disposition of Treasury Shares through Third-party Allotment Associated with Introduction of New Performance-based Share Compensation Plan
-
Consolidated Financial Information for the First Quarter of the Fiscal Year Ending March 31, 2019
-
Announcement Regarding the Setting of Terms for Issuance of Stock Acquisition Rights(Stock Options as Stock-Linked Compensation) to Corporate Executive Officers
-
(Updated)Partial Revision to the “Notice of Acquisition (100% Ownership) of US Company,Praxair, Inc.’s European Businesses”
-
Announcement Regarding the Issuance of Stock Acquisition Rights(Stock Options as Stock-Linked Compensation) to Executive Officers, etc.
-
Announcement Regarding the Issuance of Stock Acquisition Rights(Stock Options as Stock-Linked Compensation) to Corporate Executive Officers
-
Notice of Acquisition (100% Ownership) of US Company, Praxair, Inc.’s European Businesses
-
Announcement Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2022 and Zero Coupon Convertible Bonds due 2024
-
Notice on Introduction of New Performance-based Share Compensation Plan
-
Notice Regarding Result and Completion of Acquisition of Treasury Stock
-
Notice Regarding Distribution of Dividends from Surplus
-
Notice Regarding Result of Acquisition of Treasury Stock through Off-Auction Own Shares Repurchase Trading System (ToSTNeT-3)
-
Notice Regarding Revision to Dividend Forecast for the Fiscal Year Ended March 31, 2018
-
Notice Regarding Acquisition of Treasury Stock and Share Buyback through Off-Auction Own Shares Repurchase Trading System (ToSTNeT-3)
-
Announcement on Determination of Acquisition Price through Off-Auction Own Shares Repurchase Trading System (ToSTNeT-3)
-
Condensed Consolidated Financial Information for the Fiscal Year Ended March 31, 2018
-
Mitsubishi Chemical Announces MMA Monomer and PMMA Plants Start Commercial Operations in Saudi Arabia
-
Notice Regarding Changes in Representative Corporate Executive Officers and Corporate Executive Officer
-
Revision to Consolidated Financial Results Forecast for Fiscal Year Ending March 31, 2018
-
Financial Results Announcement for the Third Quarter of the Fiscal Year Ending March 31, 2018
2017
-
Notice Regarding Change in Representative Directors at Consolidated Subsidiary (Mitsubishi Chemical Corporation)
-
Consolidated Financial Information for the First Half of the Fiscal Year Ending March 31, 2018
-
Notice Concerning Sale of Shares Held by Untraceable Shareholders
-
Revision of Forecasts for Consolidated Financial Results and Dividends for Fiscal Year Ending March 31, 2018
-
Results Announcement for the First Quarter of the Fiscal Year Ending March 31, 2018
-
Announcement Regarding the Setting of Terms for Issuance of Stock Acquisition Rights
(Stock Options as Stock-Linked Compensation) to corporate executive officers -
Mitsubishi Tanabe Pharma to Acquire NeuroDerm Ltd.
-
Announcement Regarding the Issuance of Stock Acquisition Rights (Stock Options as Stock-Linked Compensation) to Executive Officers, etc.
-
Announcement Regarding the Issuance of Stock Acquisition Rights (Stock Options as Stock-Linked Compensation) to Corporate Executive Officers
-
Announcement of Additional Disclosure of “Condensed Consolidated Financial Information for the Fiscal Year Ended March 31, 2017 Announced on May 12, 2017
-
Notice Regarding Distribution of Dividends from Surplus
-
Financial Results Announcement for the Fiscal Year Ended March 31, 2017
-
Notice Regarding Revision to Dividend Forecast for the Fiscal Year Ended March 31, 2017
-
Announcement Regarding Result and Completion of Repurchase of Treasury Stock
through Off-Auction Treasury Stock Repurchase Trading System (ToSTNeT-3) -
Announcement Regarding the Issuance of Zero Coupon Convertible Bonds due 2022
and Zero Coupon Convertible Bonds due 2024 -
Announcement Regarding Repurchase of Treasury Stock
-
Financial Results Announcement for the Third Quarter of the Fiscal Year Ending March 31, 2017
-
Revision of Forecasts for Consolidated Financial Results and Dividends
for Fiscal Year Ending March 31, 2017
2016
-
Notice Regarding a Corporate Split-Off
-
Announcement Regarding Disposition of Treasury Shares
via Allotment to Subsidiary -
Financial Results Announcement for the First Half of the Fiscal Year Ending March 31, 2017
-
Revision to First Half and Full Year Consolidated Financial Results Forecasts
for Fiscal Year Ending March 31, 2017 -
Announcement regarding the Conversion of Nippon Kasei Chemical
by means of the Share Exchange into a Wholly-Owned Subsidiary of
Mitsubishi Chemical Corporation -
Notice Regarding Change in Trade Name of Consolidated Subsidiary
-
Financial Results Announcement for the First Quarter of the Fiscal Year Ending March 31, 2017
-
Announcement of Commencement of Tender Offer for Shares of
The Nippon Synthetic Chemical Industry Co., Ltd. by Our Consolidated Subsidiaries -
Notice Regarding Reorganization of Purified Terephtharic Acid Business
in India and China -
Announcement Regarding the Setting of Terms for Issuance of Stock Acquisition Rights
(Stock Options as Stock-Linked Compensation) to Directors -
Announcement Regarding the Issuance of Stock Acquisition Rights (Stock Options as Stock-Linked Compensation) to Corporate Executive Officers
-
Announcement Regarding the Issuance of Stock Acquisition Rights (Stock Options as Stock-Linked Compensation) to Executive Officers, etc.
-
Notice Regarding Top Executives and Management Structure of New Integrated Company
-
Notice Regarding Distribution of Dividends from Surplus
-
Financial Results Announcement for the Fiscal Year Ended March 31, 2016
-
Notice Regarding Revision to Dividend Forecast for the Fiscal Year Ended March 31, 2016
-
Top Executives Named for Newly Formed
Asahi Kasei Mitsubishi Chemical Ethylene Corporation -
Notice Regarding Trade Name of New Integrated Company
-
Notice Regarding a Corporate Split-Off (Simplified/Abbreviated Split-Off)
-
Financial Results Announcement for the Third Quarter of the Fiscal Year Ending March 31, 2016
-
Recognition of Impairment Loss and Revision to Consolidated Financial Results Forecasts
for the Fiscal Year Ending March 31, 2016
2015
-
Formulation of APTSIS 20 New Medium-Term Management Plan
-
Notice Regarding Integration of Three Consolidated Subsidiaries
-
Financial Results Announcement for the First Half of the Fiscal Year Ending March 31, 2016
-
Revision to Consolidated Financial Results Forecasts for the Fiscal Year Ending March 31, 2016
-
Announcement Regarding the Setting of Terms for Issuance of Stock Acquisition Rights (Stock Options as Stock-Linked Compensation) to Directors
-
Announcement Regarding the Issuance of Stock Acquisition Rights
(Stock Options as Stock-Linked Compensation) to Executive Officers, etc. -
Announcement Regarding the Issuance of Stock Acquisition Rights
(Stock Options as Stock-Linked Compensation) to Directors -
Amendment to "Announcement Regarding the Issuance of Stock Acquisition Rights (Stock Options as Stock-Linked Compensation) to Directors"
-
Financial Results Announcement for the First Quarter of the Fiscal Year Ending March 31, 2016
-
Revision to Consolidated Financial Results Forecasts for the First Half of Fiscal Year Ending March 31, 2016
-
Mitsubishi Chemical Holdings Group Begins Study of Organizational Restructuring
with an Eye toward Integration of Chemical Operating Companies -
Establishment of a Joint Venture for Operation of Unified Naphtha Cracker in Mizushima
-
Partial Amendment to the Articles of Incorporation
-
Financial Results Announcement for the Fiscal Year Ended March 31, 2015
-
Announcement Regarding Changes in Representative Corporate Executive Officers
-
Revision of Forecasts for Consolidated Financial Results and Dividends for the Fiscal Year Ending March 31, 2015
-
Notice Regarding Change in Representative Directors
-
(Corrections) Notice on Acquisition of Treasury Stock from a Subsidiary -Acquisition of Treasury Stock Pursuant to Article 163 of the Companies Act-
-
Notice on Acquisition of Treasury Stock from a Subsidiary
-
Financial Results Announcement for the Third Quarter of the Fiscal Year Ending March 31, 2015
2014
-
Announcement Regarding Executive Personnel Changes and Transfer to a Company with Committees
-
Revision to Consolidated Financial Results Forecasts for the Fiscal Year Ending March 31, 2015
-
Announcement of Results of Tender Offer for Shares of Taiyo Nippon Sanso Corporation (TSE Code: 4091) and Change in Subsidiary
-
Financial Results Announcement for the First Half of the Fiscal Year Ending March 31, 2015
-
Revision to the Consolidated Financial Results Forecasts for the First Half of Fiscal Year Ending March 31, 2015
-
Mitsubishi Tanabe Pharma Announces a Revision to the Consolidated Financial Forecasts for Fiscal Year Ending March 31, 2015
-
Announcement of Commencement of Tender Offer for Shares of Taiyo Nippon Sanso Corporation (TSE Code: 4091)
-
Financial Results Announcement for the First Quarter of the Fiscal Year Ending March 31, 2015
-
Mitsubishi Rayon Announces Establishment of MMA Monomer/PMMA Joint Venture in Saudi Arabia, and Order for Plant Construction
-
Notice Regarding Voluntary Adoption of International Financial Reporting Standards (IFRS)
-
Notice Regarding Execution of an Agreement in connection with Tender Offer by Mitsubishi Chemical Holdings Corporation for Shares of Taiyo Nippon Sanso Corporation
-
Financial Results Announcement for the Fiscal Year Ended March 31, 2014
-
Changes in Representative Directors
-
Mitsubishi Chemical Holdings to Establish Life Science Institute, Inc.
-
Revision to Consolidated Financial Results Forecasts for Fiscal Year Ending March 31, 2014
-
Financial Results Announcement for the Third Quarter of the Fiscal Year Ending March 31, 2014
2013 and before
-
Revision to Consolidated Financial Results Forecasts for Fiscal Year Ending March 31, 2014
-
Financial Results Announcement for the First Half of the Fiscal Year Ending March 31, 2014
-
Revision to the Consolidated Financial Results Forecasts for the Fist Half of Fiscal Year Ending March 31, 2014
-
Mitsubishi Tanabe Pharma Announces Notice Regarding Administrative Action Related to Violation of Pharmaceutical Affairs Law of Japan
-
Notice of change in the number of shares constituting one unit and amendment to the Articles of Incorporation
-
Notice regarding the Capital and Business Alliance between Mitsubishi Chemical Group Corporation and Taiyo Nippon Sanso Corporation
-
Mitsubishi Tanabe Pharma Announces a Revision to 2Q Consolidated Financial Forecasts for Fiscal Year Ending March 31, 2014
-
Notice Regarding Completion of Acquisition of Shares of Medicago, lnc., a Pharmaceutical Company Based in Canada, Which Has Become a Subsidiary of Mitsubishi Tanabe Pharma
-
Progress in study for unification of naphtha cracker facilities in Mizushima
-
Financial Results Announcement for the First Quarter of the Fiscal Year Ending March 31, 2014
-
Notice Regarding the Acquisition of Medicago Inc.
-
Financial Results Announcement for the Fiscal Year Ended March 31, 2013
-
Announcement Regarding the Medium-term Management Plan, APTSIS 15
-
Completion of Acquisition of the Qualicaps Co., Ltd.
-
Revision to Consolidated Financial Results Forecasts for the Fiscal Year Ending March 31, 2013
-
Financial Results Announcement for the Third Quarter of the Fiscal Year Ending March 31, 2013
